protection and safety policies and practices 

Altasciences pays particular attention to personal information to ensure that it is kept completely confidential. Access to this information is granted only to authorized Altasciences personnel, sponsors and regulatory agencies. 

The consent

Most of the information that we collect about you is gathered when you inquire about participating in one of our clinical trials. At that time, we ask only for information needed to process your request, and that will help us present studies that may interest you or correspond to your profile. It is important for us to obtain your consent to collect, use and communicate your personal information. Your consent must be informed and it must be given for a specific purpose. Sometimes, you may be asked to give an explicit consent. There are different types of explicit consent, like checking a box when you agree to receive communications, or signing an application form to show you accept its conditions of use and disclosure.

Documents

The results of a study may be passed on to the appropriate authorities, to the sponsor, and to the manufacturer of the drug under study. All essential documents and records will be maintained at Altasciences for a period of at least 25 years.

Your name and address will be kept confidential. You will only be referred to by a code number and your initials.

Your name and address will be kept confidential. You will only be referred to by a code number and your initials. Representatives of the sponsor, institutional review board, or local or foreign regulatory authorities (such as Health Canada, the Food and Drug Administration and the European Medicines Agency) may wish to examine your records to verify the information collected during the screening tests and throughout the study. They all subscribe to a strict confidentiality policy. Your identity will also remain confidential if the results of this study are published.